Investors

banner

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Semler Scientific Expands Board of Directors with Appointment of Policy Expert Cindy Moon
SANTA CLARA, Calif. , Nov. 12, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced the appointment of Cindy Moon , a D.C.-based, healthcare payment
View HTML
Toggle Summary Semler Reports Record Third Quarter and Year-to-Date 2020 Financial Results
2020 Q3 HIGHLIGHTS compared to Q2 2020:   - Revenues were $10,727,000, an increase of $4,354,000, or 68%, compared to $6,373,000   - Pre-tax net income of $5,595,000, an increase of $4,605,000, or 465%, compared to $990,000   - Net income was $4,866,000, or $0.74 per basic share and $0.61 per
View HTML
Toggle Summary Semler to Report Third Quarter and First Nine Months of 2020 Financial Results and Host Conference Call on November 5, 2020
SAN JOSE, Calif. , Oct. 22, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the third quarter ended
View HTML
Toggle Summary Semler to Participate in Upcoming Investor Conferences
SAN JOSE, Calif. , Sept. 8, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its chief executive officer, Doug Murphy-Chutorian , and chief
View HTML
Toggle Summary Semler Scientific Expands Board of Directors with Appointment of Industry Veteran Daniel Messina
SAN JOSE, Calif. , Aug. 17, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced the appointment of Daniel Messina , an experienced and well regarded
View HTML
Toggle Summary Semler Reports Second Quarter and First Half 2020 Financial Results
2020 Q2 HIGHLIGHTS compared to the corresponding period of 2019:   -- Revenues were $6,373,000, a decrease of 20%   -- Pre-tax net income was $990,000, a decrease of $1,706,000   -- Net income was $0.16 per basic share and $0.13 per diluted share, compared to $0.41 per basic share and $0.32 per
View HTML
Toggle Summary Semler to Report Second Quarter and First Half 2020 Financial Results and Host Conference Call on August 3, 2020
SAN JOSE, Calif. , July 27, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the second quarter and first
View HTML
Toggle Summary Semler Reports First Quarter 2020 Financial Results
2020 Q1 HIGHLIGHTS compared to the corresponding period of 2019: - Revenues were $9,430,000, which is an increase of 39% - Pre-tax net income of $3,450,000, an increase of $1,596,000, or 86%, compared to $1,854,000 - Net income grew to $0.41 per basic share and $0.33 per diluted share, compared to
View HTML
Toggle Summary Semler to Report First Quarter 2020 Financial Results and Host Conference Call on May 4, 2020
SAN JOSE, Calif. , April 21, 2020 /PRNewswire/ -- Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended March
View HTML
Toggle Summary Semler Reports Record Fourth Quarter and Year End 2019 Financial Results
2019 HIGHLIGHTS compared to 2018: - Annual revenues increased by 52% - Pre-tax income of $10,701,000, an increase of $5,661,000, or 112%, compared to $5,040,000 - Net income after tax grew to $2.34 per basic share and $1.88 per diluted share, compared to $0.82 per basic share and $0.66 per diluted
View HTML

Contact Us

Semler Scientific, Inc.
2344 Walsh Avenue
Santa Clara, CA 95051
877-774-4211